August 6, 2026 · Annals of surgical oncology · DOI: 10.1245/s10434-026-20337-5

Association of Cancer Center Designation with Multimodality Treatment, Perioperative Outcomes, and Survival among Older Adults with Pancreatic Ductal Adenocarcinoma

Listen to this summary

The authors aimed to investigate how cancer center designation affects treatment patterns, perioperative outcomes, and survival rates among older adults with stage I-III pancreatic ductal adenocarcinoma (PDAC). Their analysis of data from the SEER-Medicare database revealed that patients treated at NCI-designated centers experienced higher rates of multimodality treatment and significantly improved survival compared to those at non-designated centers. These findings underscore the critical role of specialized cancer centers in enhancing care for PDAC patients.

Meher Angez, Selamawit Woldesenbet, Odysseas P Chatzipanagiotou, Areesh Mevawalla, Elemosho Abdulaziz, Qaidar Alizai, Rabia Bega, Rida Ejaz, Timothy M Pawlik

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play